167.76
0.71%
1.19
プレマーケット:
168.43
0.67
+0.40%
前日終値:
$166.57
開ける:
$166.91
24時間の取引高:
4.27M
Relative Volume:
0.86
時価総額:
$294.70B
収益:
$55.53B
当期純損益:
$5.12B
株価収益率:
45.96
EPS:
3.65
ネットキャッシュフロー:
$15.62B
1週間 パフォーマンス:
-1.52%
1か月 パフォーマンス:
-11.17%
6か月 パフォーマンス:
+1.94%
1年 パフォーマンス:
+21.29%
Abbvie Inc Stock (ABBV) Company Profile
ABBV を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
ABBV | 167.76 | 294.70B | 55.53B | 5.12B | 15.62B | 3.65 |
LLY | 753.41 | 693.54B | 40.86B | 8.37B | -2.28B | 5.4193 |
NVO | 105.27 | 465.74B | 39.36B | 13.79B | 9.83B | 2.4077 |
JNJ | 153.11 | 353.35B | 87.70B | 14.68B | 19.03B | 13.47 |
MRK | 97.44 | 248.54B | 63.17B | 12.15B | 14.84B | 1.80 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-10-17 | 開始されました | Bernstein | Mkt Perform |
2024-06-05 | アップグレード | HSBC Securities | Hold → Buy |
2024-05-17 | 開始されました | Cantor Fitzgerald | Overweight |
2024-01-29 | アップグレード | William Blair | Mkt Perform → Outperform |
2023-12-18 | ダウングレード | HSBC Securities | Buy → Hold |
2023-12-11 | アップグレード | Goldman | Neutral → Buy |
2023-11-09 | 開始されました | Deutsche Bank | Hold |
2023-10-30 | アップグレード | Barclays | Equal Weight → Overweight |
2023-10-20 | 再開されました | UBS | Neutral |
2023-09-29 | 開始されました | Raymond James | Outperform |
2023-07-25 | 開始されました | William Blair | Mkt Perform |
2023-07-14 | 開始されました | HSBC Securities | Buy |
2023-04-05 | ダウングレード | Argus | Buy → Hold |
2023-03-01 | 開始されました | Guggenheim | Buy |
2023-02-22 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
2023-02-10 | アップグレード | SVB Securities | Underperform → Market Perform |
2022-11-18 | 開始されました | Credit Suisse | Outperform |
2022-11-08 | ダウングレード | Societe Generale | Buy → Hold |
2022-08-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
2022-05-23 | 開始されました | SVB Leerink | Underperform |
2022-05-06 | ダウングレード | Daiwa Securities | Outperform → Neutral |
2022-04-06 | 再開されました | Morgan Stanley | Overweight |
2022-02-28 | ダウングレード | UBS | Buy → Neutral |
2022-02-03 | 繰り返されました | BMO Capital Markets | Outperform |
2022-02-03 | 繰り返されました | Barclays | Equal Weight |
2022-02-03 | 繰り返されました | BofA Securities | Neutral |
2022-02-03 | 繰り返されました | Goldman | Neutral |
2022-01-13 | 開始されました | Redburn | Buy |
2022-01-12 | 繰り返されました | BMO Capital Markets | Outperform |
2021-12-09 | 再開されました | Wells Fargo | Overweight |
2021-11-23 | アップグレード | Societe Generale | Hold → Buy |
2021-07-27 | 再開されました | Truist | Buy |
2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
2020-11-10 | 再開されました | Bernstein | Outperform |
2020-09-29 | 開始されました | Berenberg | Hold |
2020-06-23 | アップグレード | Atlantic Equities | Neutral → Overweight |
2020-06-09 | アップグレード | Wolfe Research | Peer Perform → Outperform |
2020-06-02 | アップグレード | Argus | Hold → Buy |
2020-05-18 | 再開されました | BofA/Merrill | Neutral |
2020-05-12 | アップグレード | JP Morgan | Neutral → Overweight |
2020-05-11 | 再開されました | Morgan Stanley | Overweight |
2020-04-20 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
2020-03-23 | ダウングレード | Societe Generale | Buy → Hold |
2020-02-27 | 開始されました | Barclays | Equal Weight |
2020-02-06 | 開始されました | Mizuho | Buy |
2020-01-07 | 開始されました | RBC Capital Mkts | Sector Perform |
2019-12-26 | 繰り返されました | Cowen | Outperform |
2019-09-26 | アップグレード | Citigroup | Neutral → Buy |
2019-08-20 | アップグレード | Piper Jaffray | Neutral → Overweight |
2019-06-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
2019-06-26 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
2019-05-28 | 開始されました | Goldman | Neutral |
2019-04-29 | アップグレード | BMO Capital Markets | Underperform → Market Perform |
すべてを表示
Abbvie Inc (ABBV) 最新ニュース
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy - Yahoo Finance
AbbVie (NYSE:ABBV) Stock Price Up 0.1% Following Analyst Upgrade - MarketBeat
Altman Advisors Inc. Boosts Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Advisors Asset Management Inc. Sells 39,044 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Is Trending Stock AbbVie Inc. (ABBV) a Buy Now? - Yahoo Finance
Ontario Teachers Pension Plan Board Has $580.18 Million Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Jennison Associates LLC Purchases 145,542 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Howe & Rusling Inc. Grows Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Commerce Bank - MarketBeat
AbbVie Inc. stock rises Tuesday, still underperforms market - MarketWatch
AbbVie (NYSE:ABBV) Trading Down 0.7%Here's What Happened - MarketBeat
Counterweight Ventures LLC Raises Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Avior Wealth Management LLC - MarketBeat
AbbVie (NYSE:ABBV) Price Target Raised to $195.00 at Wells Fargo & Company - MarketBeat
Where Will AbbVie Be in 5 Years? - Yahoo Finance
PNC Financial Services Group Inc. Lowers Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
B. Metzler seel. Sohn & Co. Holding AG Makes New $89.42 Million Investment in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Banque Cantonale Vaudoise Purchases 4,650 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Beddow Capital Management Inc. Has $7.09 Million Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Fifth Third Wealth Advisors LLC - MarketBeat
AbbVie's (NYSE:ABBV) Dividend Will Be Increased To $1.64 - Simply Wall St
AbbVie Inc. (NYSE:ABBV) Shares Bought by Meeder Asset Management Inc. - MarketBeat
Caprock Group LLC Grows Stake in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Quest Partners LLC - MarketBeat
EC grants approval for AbbVie’s Elahere in ovarian cancer - The Pharma Letter
Thrivent Financial for Lutherans Boosts Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine - Yahoo Finance
Regenerative Medicine Industry May See a Big Move | AbbVie, ViaCyte, Cook Biotech - openPR
AbbVie Inc. (NYSE:ABBV) Short Interest Up 12.1% in October - MarketBeat
AbbVie snaps eight straight sessions of losses - MSN
AbbVie (NYSE:ABBV) Trading Up 0.2%Time to Buy? - MarketBeat
Mawer Investment Management Ltd. Sells 14,746 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe - Yahoo Finance
Napa Wealth Management Buys Shares of 11,771 AbbVie Inc. (NYSE:ABBV) - MarketBeat
Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products - AbbVie
Allergan Aesthetics Launches Free Business Training Platform for Healthcare Practices | ABBV Stock News - StockTitan
GLOBALT Investments LLC GA Invests $3.78 Million in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Richard C. Young & CO. LTD. - MarketBeat
Aldeyra's Dry Eye Drug Gets FDA Review, Expands $400M AbbVie Partnership Deal | ALDX Stock News - StockTitan
Aljian Capital Management LLC Invests $1.33 Million in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by MAI Capital Management - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by AMG National Trust Bank - MarketBeat
AbbVie bags EU nod for key drug from ImmunoGen takeover - pharmaphorum
AbbVie Gets European OK of Elahere in Platinum-Resistant Ovarian Cancer - MarketWatch
AbbVie’s Elahere wins European approval for certain ovarian cancers - Pharmaceutical Technology
AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer - PR Newswire
AbbVie's (NYSE:ABBV) Shareholders Will Receive A Bigger Dividend Than Last Year - Yahoo Finance
Atlanta Consulting Group Advisors LLC Acquires Shares of 5,060 AbbVie Inc. (NYSE:ABBV) - MarketBeat
Sawgrass Asset Management LLC Has $13.61 Million Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Sold by Mutual of America Capital Management LLC - MarketBeat
Why AbbVie’s (ABBV) Drug Setback Creates A Prime Buy-The-Dip Moment - MSN
Abbvie Inc (ABBV) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):